1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Travel Vaccines Market – By Product

1.3.2        North America Travel Vaccines Market – By Application

1.3.3        North America Travel Vaccines Market – By Country

2.           North America Travel Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Travel Vaccines Market– Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Travel Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Travel and Tourism

5.1.2        Rising Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        High Cost of Travel Vaccines

5.3         Market Opportunities

5.3.1        Rising Awareness Regarding Vaccines

5.4         Future Trends

5.4.1        Never-ending Demand for Vaccines

5.5         Impact Analysis

6.           Travel Vaccines Market – North America Analysis

6.1         North America Travel Vaccines Marker Revenue Forecast and Analysis

7.           North America Travel Vaccines Market Analysis – By Product

7.1         Overview

7.2         North America Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3         Hepatitis A

7.3.1        Overview

7.3.2        Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Hepatitis B

7.4.1        Overview

7.4.2        Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Meningococcal Vaccines

7.5.1        Overview

7.5.2        Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.           North America Travel Vaccines Market Analysis – By Application

8.1         Overview

8.2         North America Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3         Domestic Travel

8.3.1        Overview

8.3.2        Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Outbound Travel

8.4.1        Overview

8.4.2        Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9.           North America Travel Vaccines Market – Country Analysis

9.1         North America: Travel Vaccines Market

9.1.1        North America: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1          US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1          US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2          US: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3          US: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2          Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1          Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2          Canada: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3          Canada: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3          Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1          Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2          Mexico: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3          Mexico: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10.        Travel Vaccines Market–Industry Landscape

10.1      Overview

10.2      Growth Strategies in the Travel Vaccines Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.4      Inorganic Developments

10.4.1     Overview

11.        Company Profiles

11.1      GlaxoSmithKline plc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Merck & Co., Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sanofi

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Novartis AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Pfizer Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Dynavax Technologies

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Emergent BioSolutions Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Abbott

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Valneva SE.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             US: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Canada: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Canada: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Mexico: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Mexico: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Organic Developments Done by Companies

Table 8.             Inorganic Developments Done by Companies

Table 9.             Glossary of Terms, North America Travel vaccines Market

LIST OF FIGURES

Figure 1.           North America Travel Vaccines Market Segmentation

Figure 2.           North America Travel Vaccines Market – By Country

Figure 3.           North America Travel Vaccines Market Overview

Figure 4.           North America Outbound Segment Held Largest Share of Travel Vaccines Market by Product

Figure 5.           US to Show Significant Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           North America Travel Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10.        North America Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

Figure 11.        North America Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 16.        North America Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 19.        North America: Travel Vaccines Market, by Country, 2020 & 2028 (%)

Figure 20.        US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 21.        Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Growth Strategies in the Travel Vaccines Market, (%)